A citation-based method for searching scientific literature

Christophe Massard, Stefan Michiels, Charles Ferté, Marie-Cécile Le Deley, Ludovic Lacroix, Antoine Hollebecque, Loic Verlingue, Ecaterina Ileana, Silvia Rosellini, Samy Ammari, Maud Ngo-Camus, Rastislav Bahleda, Anas Gazzah, Andrea Varga, Sophie Postel-Vinay, Yohann Loriot, Caroline Even, Ingrid Breuskin, Nathalie Auger, Bastien Job, Thierry De Baere, Frederic Deschamps, Philippe Vielh, Jean-Yves Scoazec, Vladimir Lazar, Catherine Richon, Vincent Ribrag, Eric Deutsch, Eric Angevin, Gilles Vassal, Alexander Eggermont, Fabrice André, Jean-Charles Soria. Cancer Discov 2017
Times Cited: 368



Tracy L Stockley, Amit M Oza, Hal K Berman, Natasha B Leighl, Jennifer J Knox, Frances A Shepherd, Eric X Chen, Monika K Krzyzanowska, Neesha Dhani, Anthony M Joshua, Ming-Sound Tsao, Stefano Serra, Blaise Clarke, Michael H Roehrl, Tong Zhang, Mahadeo A Sukhai, Nadia Califaretti, Mateya Trinkaus, Patricia Shaw, Theodorus van der Kwast, Lisa Wang, Carl Virtanen, Raymond H Kim, Albiruni R A Razak, Aaron R Hansen, Celeste Yu, Trevor J Pugh, Suzanne Kamel-Reid, Lillian L Siu, Philippe L Bedard. Genome Med 2016
Times Cited: 153




List of shared articles



Times cited

Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
Apostolia M Tsimberidou, Elena Fountzilas, Leonidas Bleris, Razelle Kurzrock. Semin Cancer Biol 2022
13

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Christoph Kornauth, Tea Pemovska, Gregory I Vladimer, Günther Bayer, Michael Bergmann, Sandra Eder, Ruth Eichner, Martin Erl, Harald Esterbauer, Ruth Exner,[...]. Cancer Discov 2022
14

Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis.
Sarah G Ayton, Martina Pavlicova, Carla Daniela Robles-Espinoza, José G Tamez Peña, Víctor Treviño. Genet Med 2022
1

Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Valentin Van den Bossche, Hannah Zaryouh, Marianela Vara-Messler, Julie Vignau, Jean-Pascal Machiels, An Wouters, Sandra Schmitz, Cyril Corbet. Drug Resist Updat 2022
9

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.
Pablo Berlanga, Gaelle Pierron, Ludovic Lacroix, Mathieu Chicard, Tiphaine Adam de Beaumais, Antonin Marchais, Anne C Harttrampf, Yasmine Iddir, Alicia Larive, Aroa Soriano Fernandez,[...]. Cancer Discov 2022
8

Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer.
Etienne Gouton, Nausicaa Malissen, Nicolas André, Arnaud Jeanson, Annick Pelletier, Albane Testot-Ferry, Caroline Gaudy-Marqueste, Laetitia Dahan, Emeline Tabouret, Thomas Chevalier,[...]. Curr Oncol 2022
1

Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards.
Tara M Love, Daniel A Anaya, Matthew S Prime, Luke Ardolino, Okan Ekinci. PLoS One 2022
0

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Emilien Billon, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle,[...]. Cancers (Basel) 2022
0

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.
Edoardo Crimini, Matteo Repetto, Paolo Tarantino, Liliana Ascione, Gabriele Antonarelli, Elena Guerini Rocco, Massimo Barberis, Luca Mazzarella, Giuseppe Curigliano. Cancers (Basel) 2022
0

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data.
Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Heechul Shin, Eunyoung Kang, Eun-Kyu Kim, Sejoon Lee, Ji Won Woo, Hee Young Na, Soomin Ahn,[...]. J Breast Cancer 2022
0

Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, Ludovic Lacroix, Etienne Rouleau, Anas Gazzah, Rastilav Bahleda, David Planchard, Andrea Varga, Capucine Baldini,[...]. JCO Precis Oncol 2022
0

Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
Theresia Pichler, Amy Rohrmoser, Anne Letsch, C Benedikt Westphalen, Ulrich Keilholz, Volker Heinemann, Mario Lamping, Philipp J Jost, Kristina Riedmann, Peter Herschbach,[...]. Support Care Cancer 2021
2

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Elena Sultova, C Benedikt Westphalen, Andreas Jung, Joerg Kumbrink, Thomas Kirchner, Doris Mayr, Martina Rudelius, Steffen Ormanns, Volker Heinemann, Klaus H Metzeler,[...]. Arch Gynecol Obstet 2021
8

Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
Junko Kikuchi, Yoshihito Ohhara, Kohichi Takada, Hiroki Tanabe, Kazuteru Hatanaka, Toraji Amano, Kanako C Hatanaka, Yutaka Hatanaka, Takashi Mitamura, Momoko Kato,[...]. Jpn J Clin Oncol 2021
4

Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Rouven Hoefflin, Adriana Lazarou, Maria Elena Hess, Meike Reiser, Julius Wehrle, Patrick Metzger, Anna Verena Frey, Heiko Becker, Konrad Aumann, Kai Berner,[...]. Cancers (Basel) 2021
7